MDCX

Conviction 0Scan · Mon, Aug 10, 2026

MDCX$0.3271+9.18%

ResistanceSupportVol 14

Vol MA14 1.91M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Medicus Pharma Ltd.Pharmaceutical Preparationswww.medicuspharma.com ↗

Price0.3271

Change+9.18%

Gap+5.87%

Rel volume0.77×

Avg volume1.74M

Avg $ vol559.46K

SMA 200.3303

SMA 500.3675

SMA 2000.9817

Price vs 50-11.00%

Price vs 200-66.68%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3826

RSI (14)48

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D46 / 36

ADX (14)12

+DI / −DI23 / 22

RSI divergence—

MACD divergence—

ATR %+11.09%

ADR %10.12%

52w high2.80

52w low0.2626

From 52w high-88.32%

Above 52w low+24.56%

New 52w highNo

SqueezeOff

Bollinger width52.51%

%B0.48

Donchian pos45.70%

Donchian high0.4174

Donchian low0.2511

AVWAP (52w high)0.5385

vs AVWAP high-39.26%

AVWAP (52w low)0.3514

vs AVWAP low-6.91%

OBV trendFlat

Chaikin MF (20)-0.14

Today vs 20d0.77×

Avg vol (14d)1.91M

Avg vol (20d)1.74M

Avg $ vol (20d)559.46K

Market cap—

RS 3m (vs SPY)-10.28%

RS 6m (vs SPY)-86.63%

RS line new highNo

Trend template0/8

Technical rank10.9

1 week+8.67%

1 month-19.75%

3 months-2.36%

6 months-70.53%

1 year-85.00%

YTD-79.56%

P/E-0.37

P/B13.17

P/S—

P/FCF—

EPS-2.74

Div yield—

ROE—

ROA—

Debt/Eq1.77

Current1.22

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-323.84%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value13.45M

Revenue—

Net income-9.04M

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out56.66M

Employees16

ListedWed, Nov 22, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank10.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.4841

Support0.2931

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MDCX

All disclosures →

No recent disclosed trades by Congress in MDCX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MDCX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
May Sara R. Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04
Mehmud Faisal Chief Medical Officer · Stock Option (right to buy) · 2026-06-03	Grant	250K	$0	2026-06-03	2026-06-04
Ashton William Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04
MAHAFFY PATRICK J Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04
Kaiser Larry Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04
Raju Ajay Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04
Bonner Carolyn F. President and CFO · Stock Option (right to buy) · 2026-06-03	Grant	250K	$0	2026-06-03	2026-06-04
Smith Andrew Alasdair Chief Operating Officer · Stock Option (right to buy) · 2026-06-03	Grant	200K	$0	2026-06-03	2026-06-04
Rodgers Cathy McMorris Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04
FISHMAN BARRY Director · Stock Option (right to buy) · 2026-06-03	Grant	50K	$0	2026-06-03	2026-06-04

SEC filings

EDGAR filings in MDCX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.